speb/financial-data huggingface dataset:
IX balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 345841000000.00
IX income_statement (annual, 2022-03-31) — Normalized Income: -57623025498.24
IX cash_flow (annual, 2022-03-31) — Operating Cash Flow: 1103370000000.00
IX cash_flow (annual, 2022-03-31) — Operating Gains Losses: -274209000000.00
IX income_statement (annual, 2022-03-31) — Operating Revenue: 1562852000000.00
IX balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 1193399778.00
IX balance_sheet (annual, 2022-03-31) — Other Current Borrowings: 399589000000.00
IX balance_sheet (annual, 2022-03-31) — Other Equity Adjustments: -16041000000.00
IX income_statement (annual, 2022-03-31) — Other Gand A: 136431000000.00
IX cash_flow (annual, 2022-03-31) — Other Non Cash Items: 363253000000.00
IX income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: -20494000000.00
IX balance_sheet (annual, 2022-03-31) — Other Properties: 1734039000000.00
IX balance_sheet (annual, 2022-03-31) — Other Receivables: 1088698000000.00
IX balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 2174891000000.00
IX balance_sheet (annual, 2022-03-31) — Payables: 406762000000.00
IX balance_sheet (annual, 2022-03-31) — Payables And Accrued Expenses: 406762000000.00
IX balance_sheet (annual, 2022-03-31) — Preferred Securities Outside Stock Equity: 0.00
IX income_statement (annual, 2022-03-31) — Pretax Income: 509447000000.00
IX cash_flow (annual, 2022-03-31) — Purchase Of Business: -87582000000.00
IX cash_flow (annual, 2022-03-31) — Purchase Of Investment: -648099000000.00
IX cash_flow (annual, 2022-03-31) — Purchase Of PPE: -917296000000.00
IX balance_sheet (annual, 2022-03-31) — Receivables: 1448647000000.00
IX income_statement (annual, 2022-03-31) — Reconciled Depreciation: 320339000000.00
IX income_statement (annual, 2022-03-31) — Rent And Landing Fees: 322070000000.00
IX income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 322070000000.00
IX cash_flow (annual, 2022-03-31) — Repayment Of Debt: -1168113000000.00
IX cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: -50001000000.00
IX income_statement (annual, 2022-03-31) — Restructuring And Mergern Acquisition: 0.00
IX balance_sheet (annual, 2022-03-31) — Retained Earnings: 2909317000000.00
IX income_statement (annual, 2022-03-31) — Salaries And Wages: 300590000000.00
IX cash_flow (annual, 2022-03-31) — Sale Of Business: 252921000000.00
IX cash_flow (annual, 2022-03-31) — Sale Of Investment: 449288000000.00
IX cash_flow (annual, 2022-03-31) — Sale Of PPE: 147104000000.00
IX income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 76678000000.00
IX income_statement (annual, 2022-03-31) — Selling General And Administration: 1199338000000.00
IX balance_sheet (annual, 2022-03-31) — Share Issued: 1258277087.00
IX cash_flow (annual, 2022-03-31) — Short Term Debt Issuance: 96383000000.00
IX cash_flow (annual, 2022-03-31) — Short Term Debt Payments: -7500000000.00
IX income_statement (annual, 2022-03-31) — Special Income Charges: 156333000000.00
IX balance_sheet (annual, 2022-03-31) — Stockholders Equity: 3261419000000.00
IX balance_sheet (annual, 2022-03-31) — Tangible Book Value: 3261419000000.00
IX income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 216731974501.76
IX income_statement (annual, 2022-03-31) — Tax Provision: 186594000000.00
IX income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.37
IX balance_sheet (annual, 2022-03-31) — Total Assets: 14270672000000.00
IX balance_sheet (annual, 2022-03-31) — Total Capitalization: 7688465000000.00
IX balance_sheet (annual, 2022-03-31) — Total Debt: 4866685000000.00
IX balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 3371401000000.00
IX balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 10899271000000.00
IX balance_sheet (annual, 2022-03-31) — Total Tax Payable: 115340000000.00
IX income_statement (annual, 2022-03-31) — Total Unusual Items: 591731000000.00
IX income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 591731000000.00
IX balance_sheet (annual, 2022-03-31) — Trading Securities: 2503000000.00
IX balance_sheet (annual, 2022-03-31) — Treasury Shares Number: 64877309.00
IX balance_sheet (annual, 2022-03-31) — Treasury Stock: 113447000000.00
IX income_statement (annual, 2023-03-31) — +Total Revenue: 1631081000000.00
IX balance_sheet (annual, 2023-03-31) — Accounts Payable: 366851000000.00
IX balance_sheet (annual, 2023-03-31) — Accounts Receivable: 441803000000.00
IX balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 233169000000.00
IX cash_flow (annual, 2023-03-31) — Asset Impairment Charge: 2297000000.00
IX balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 500832000000.00
IX income_statement (annual, 2023-03-31) — Basic Average Shares: 1180356000.00
IX income_statement (annual, 2023-03-31) — Basic EPS: 231.35
IX cash_flow (annual, 2023-03-31) — Beginning Cash Position: 1091812000000.00
IX cash_flow (annual, 2023-03-31) — Capital Expenditure: -1080074000000.00
IX balance_sheet (annual, 2023-03-31) — Capital Stock: 221111000000.00
IX balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 1231860000000.00
IX balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Federal Funds Sold: 1366908000000.00
IX cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -106290000000.00
IX cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Financing Activities: 438308000000.00
IX cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Investing Activities: -1098478000000.00
IX cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Operating Activities: 913088000000.00
IX cash_flow (annual, 2023-03-31) — Change In Account Payable: -12173000000.00
IX cash_flow (annual, 2023-03-31) — Change In Income Tax Payable: -128948000000.00
IX cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -17527000000.00
IX cash_flow (annual, 2023-03-31) — Change In Other Working Capital: 121770000000.00
IX cash_flow (annual, 2023-03-31) — Change In Payable: -141121000000.00
IX cash_flow (annual, 2023-03-31) — Change In Payables And Accrued Expense: -141121000000.00
IX cash_flow (annual, 2023-03-31) — Change In Receivables: 12953000000.00
IX cash_flow (annual, 2023-03-31) — Change In Tax Payable: -128948000000.00
IX cash_flow (annual, 2023-03-31) — Change In Working Capital: -23925000000.00
IX cash_flow (annual, 2023-03-31) — Changes In Account Receivables: 12953000000.00
IX cash_flow (annual, 2023-03-31) — Changes In Cash: 252918000000.00
IX balance_sheet (annual, 2023-03-31) — Commercial Paper: 44509000000.00
IX balance_sheet (annual, 2023-03-31) — Common Stock: 221111000000.00
IX cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -106290000000.00
IX balance_sheet (annual, 2023-03-31) — Common Stock Equity: 3543607000000.00
IX cash_flow (annual, 2023-03-31) — Common Stock Payments: -52071000000.00
IX balance_sheet (annual, 2023-03-31) — Current Debt: 508796000000.00
IX balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 508796000000.00
IX cash_flow (annual, 2023-03-31) — Deferred Income Tax: 36947000000.00
IX cash_flow (annual, 2023-03-31) — Deferred Tax: 36947000000.00
IX cash_flow (annual, 2023-03-31) — Depreciation Amortization Depletion: 340252000000.00
IX income_statement (annual, 2023-03-31) — Depreciation Amortization Depletion Income Statement: 8373000000.00
IX cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 340252000000.00
IX income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 8373000000.00
IX income_statement (annual, 2023-03-31) — Depreciation Income Statement: 8373000000.00
IX income_statement (annual, 2023-03-31) — Diluted Average Shares: 1181945000.00
IX income_statement (annual, 2023-03-31) — Diluted EPS: 231.04
IX income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 290340000000.00
IX cash_flow (annual, 2023-03-31) — Earnings Losses From Equity Investments: -22081000000.00
IX cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 22178000000.00
IX cash_flow (annual, 2023-03-31) — End Cash Position: 1366908000000.00
IX cash_flow (annual, 2023-03-31) — Financing Cash Flow: 438308000000.00
IX cash_flow (annual, 2023-03-31) — Free Cash Flow: -166986000000.00
IX cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -2657000000.00
IX cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of Business: -33000000000.00
IX cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -56932000000.00
IX income_statement (annual, 2023-03-31) — Gain On Sale Of Business: 33000000000.00
IX income_statement (annual, 2023-03-31) — Gain On Sale Of Security: 24881000000.00
IX balance_sheet (annual, 2023-03-31) — Gains Losses Not Affecting Retained Earnings: 156135000000.00
IX income_statement (annual, 2023-03-31) — General And Administrative Expense: 1270299000000.00
IX balance_sheet (annual, 2023-03-31) — Gross PPE: 1962206000000.00
IX balance_sheet (annual, 2023-03-31) — Held To Maturity Securities: 114759000000.00
IX income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 2297000000.00
IX balance_sheet (annual, 2023-03-31) — Income Tax Payable: 25199000000.00
IX income_statement (annual, 2023-03-31) — Insurance And Claims: 373906000000.00
IX income_statement (annual, 2023-03-31) — Interest Expense: 127618000000.00
IX income_statement (annual, 2023-03-31) — Interest Income: 319478000000.00
IX balance_sheet (annual, 2023-03-31) — Invested Capital: 9262126000000.00
IX cash_flow (annual, 2023-03-31) — Investing Cash Flow: -1098478000000.00
IX balance_sheet (annual, 2023-03-31) — Investments And Advances: 3914788000000.00
IX cash_flow (annual, 2023-03-31) — Issuance Of Debt: 1846041000000.00
IX balance_sheet (annual, 2023-03-31) — Leases: 270939000000.00
IX balance_sheet (annual, 2023-03-31) — Long Term Debt: 5209723000000.00
IX balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 5209723000000.00
IX cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 1820633000000.00
IX cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -1158517000000.00
IX balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 1062410000000.00
IX balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 253649000000.00
IX balance_sheet (annual, 2023-03-31) — Minority Interest: 70715000000.00
IX income_statement (annual, 2023-03-31) — Minority Interests: -6593000000.00
IX cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -186843000000.00
IX cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: -52071000000.00
IX balance_sheet (annual, 2023-03-31) — Net Debt: 4486659000000.00
IX income_statement (annual, 2023-03-31) — Net Income: 290340000000.00
IX income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 290340000000.00
IX income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 296933000000.00
IX income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 290340000000.00
IX income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 290340000000.00
IX cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 296933000000.00
IX income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 296933000000.00
IX income_statement (annual, 2023-03-31) — Net Interest Income: 191860000000.00
IX cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -128490000000.00
IX cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 687524000000.00
IX cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 662116000000.00
IX cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -60217000000.00
IX cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 1383000000.00
IX balance_sheet (annual, 2023-03-31) — Net PPE: 1962206000000.00
IX cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -846622000000.00
IX cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 25408000000.00
IX balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 3543607000000.00
IX balance_sheet (annual, 2023-03-31) — Non Current Deferred Liabilities: 429063000000.00
IX balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 429063000000.00
IX income_statement (annual, 2023-03-31) — Normalized Income: -31024339962.98
IX cash_flow (annual, 2023-03-31) — Operating Cash Flow: 913088000000.00
IX cash_flow (annual, 2023-03-31) — Operating Gains Losses: -113846000000.00
IX income_statement (annual, 2023-03-31) — Operating Revenue: 1631081000000.00
IX balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 1170305869.00
IX balance_sheet (annual, 2023-03-31) — Other Current Borrowings: 464287000000.00
IX balance_sheet (annual, 2023-03-31) — Other Equity Adjustments: 156135000000.00
IX income_statement (annual, 2023-03-31) — Other Gand A: 559406000000.00
IX cash_flow (annual, 2023-03-31) — Other Non Cash Items: 366313000000.00
IX income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: -14445000000.00
IX balance_sheet (annual, 2023-03-31) — Other Properties: 1708557000000.00
IX balance_sheet (annual, 2023-03-31) — Other Receivables: 1537178000000.00
IX balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 2234608000000.00
IX balance_sheet (annual, 2023-03-31) — Payables: 392050000000.00
IX balance_sheet (annual, 2023-03-31) — Payables And Accrued Expenses: 392050000000.00
IX balance_sheet (annual, 2023-03-31) — Preferred Securities Outside Stock Equity: 945000000.00
IX income_statement (annual, 2023-03-31) — Pretax Income: 392178000000.00
IX cash_flow (annual, 2023-03-31) — Purchase Of Business: -206830000000.00
IX cash_flow (annual, 2023-03-31) — Purchase Of Investment: -637590000000.00
IX cash_flow (annual, 2023-03-31) — Purchase Of PPE: -1080074000000.00
IX balance_sheet (annual, 2023-03-31) — Receivables: 1978981000000.00
IX income_statement (annual, 2023-03-31) — Reconciled Depreciation: 340252000000.00
IX income_statement (annual, 2023-03-31) — Rent And Landing Fees: 336987000000.00
IX income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 336987000000.00
IX cash_flow (annual, 2023-03-31) — Repayment Of Debt: -1158517000000.00
IX cash_flow (annual, 2023-03-31) — Repurchase Of Capital Stock: -52071000000.00
IX income_statement (annual, 2023-03-31) — Restructuring And Mergern Acquisition: -1174000000.00
IX balance_sheet (annual, 2023-03-31) — Retained Earnings: 3054448000000.00
IX income_statement (annual, 2023-03-31) — Salaries And Wages: 321328000000.00
IX cash_flow (annual, 2023-03-31) — Sale Of Business: 19987000000.00
IX cash_flow (annual, 2023-03-31) — Sale Of Investment: 509100000000.00
IX cash_flow (annual, 2023-03-31) — Sale Of PPE: 233452000000.00
IX income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 87199000000.00
IX income_statement (annual, 2023-03-31) — Selling General And Administration: 1270299000000.00
IX balance_sheet (annual, 2023-03-31) — Share Issued: 1234849342.00
IX cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 25408000000.00
IX income_statement (annual, 2023-03-31) — Special Income Charges: 31877000000.00
IX balance_sheet (annual, 2023-03-31) — Stockholders Equity: 3543607000000.00
IX balance_sheet (annual, 2023-03-31) — Tangible Book Value: 3543607000000.00
IX income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 103081660037.02
IX income_statement (annual, 2023-03-31) — Tax Provision: 95245000000.00
IX income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.24
IX balance_sheet (annual, 2023-03-31) — Total Assets: 15289385000000.00
IX balance_sheet (annual, 2023-03-31) — Total Capitalization: 8753330000000.00
IX balance_sheet (annual, 2023-03-31) — Total Debt: 5718519000000.00
IX balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 3614322000000.00
IX balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 11675063000000.00
IX balance_sheet (annual, 2023-03-31) — Total Tax Payable: 25199000000.00
IX income_statement (annual, 2023-03-31) — Total Unusual Items: 424446000000.00
IX income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 424446000000.00
IX balance_sheet (annual, 2023-03-31) — Trading Securities: 2179000000.00
IX balance_sheet (annual, 2023-03-31) — Treasury Shares Number: 64543473.00
IX balance_sheet (annual, 2023-03-31) — Treasury Stock: 121256000000.00
IX income_statement (annual, 2024-03-31) — +Total Revenue: 1796990000000.00
IX balance_sheet (annual, 2024-03-31) — Accounts Payable: 362504000000.00
IX balance_sheet (annual, 2024-03-31) — Accounts Receivable: 401368000000.00
IX balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 233457000000.00
IX cash_flow (annual, 2024-03-31) — Asset Impairment Charge: 1724000000.00
IX balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 597601000000.00
IX income_statement (annual, 2024-03-31) — Basic Average Shares: 1159367000.00
IX income_statement (annual, 2024-03-31) — Basic EPS: 298.55
IX cash_flow (annual, 2024-03-31) — Beginning Cash Position: 1366908000000.00
IX cash_flow (annual, 2024-03-31) — Capital Expenditure: -1200874000000.00
IX balance_sheet (annual, 2024-03-31) — Capital Stock: 221111000000.00
IX balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 1032810000000.00
IX balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Federal Funds Sold: 1185307000000.00
IX cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -99900000000.00
IX cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Financing Activities: -85477000000.00
IX cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Investing Activities: -1372803000000.00
IX cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Operating Activities: 1243402000000.00
IX cash_flow (annual, 2024-03-31) — Change In Account Payable: -4427000000.00
IX cash_flow (annual, 2024-03-31) — Change In Income Tax Payable: 107881000000.00
IX cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -58126000000.00
IX cash_flow (annual, 2024-03-31) — Change In Other Working Capital: 178152000000.00
IX cash_flow (annual, 2024-03-31) — Change In Payable: 103454000000.00
IX cash_flow (annual, 2024-03-31) — Change In Payables And Accrued Expense: 103454000000.00
IX cash_flow (annual, 2024-03-31) — Change In Receivables: 5235000000.00
IX cash_flow (annual, 2024-03-31) — Change In Tax Payable: 107881000000.00
IX cash_flow (annual, 2024-03-31) — Change In Working Capital: 228715000000.00
IX cash_flow (annual, 2024-03-31) — Changes In Account Receivables: 5235000000.00
IX cash_flow (annual, 2024-03-31) — Changes In Cash: -214878000000.00
IX balance_sheet (annual, 2024-03-31) — Commercial Paper: 13849000000.00
IX balance_sheet (annual, 2024-03-31) — Common Stock: 221111000000.00
IX cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -99900000000.00
IX balance_sheet (annual, 2024-03-31) — Common Stock Equity: 3941466000000.00
IX cash_flow (annual, 2024-03-31) — Common Stock Payments: -50001000000.00
IX balance_sheet (annual, 2024-03-31) — Current Debt: 570787000000.00
IX balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 570787000000.00
IX cash_flow (annual, 2024-03-31) — Deferred Income Tax: 20000000000.00
IX cash_flow (annual, 2024-03-31) — Deferred Tax: 20000000000.00
IX cash_flow (annual, 2024-03-31) — Depreciation Amortization Depletion: 364242000000.00
IX income_statement (annual, 2024-03-31) — Depreciation Amortization Depletion Income Statement: 9256000000.00
IX cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 364242000000.00
IX income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 9256000000.00
IX income_statement (annual, 2024-03-31) — Depreciation Income Statement: 9256000000.00
IX income_statement (annual, 2024-03-31) — Diluted Average Shares: 1161310000.00
IX income_statement (annual, 2024-03-31) — Diluted EPS: 298.05
IX income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 346132000000.00
IX cash_flow (annual, 2024-03-31) — Earnings Losses From Equity Investments: -36774000000.00
IX cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 33277000000.00
IX cash_flow (annual, 2024-03-31) — End Cash Position: 1185307000000.00
IX cash_flow (annual, 2024-03-31) — Financing Cash Flow: -85477000000.00
IX cash_flow (annual, 2024-03-31) — Free Cash Flow: 42528000000.00
IX cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -3943000000.00
IX cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of Business: -72488000000.00
IX cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -53441000000.00
IX income_statement (annual, 2024-03-31) — Gain On Sale Of Business: 72488000000.00
IX income_statement (annual, 2024-03-31) — Gain On Sale Of Security: 30416000000.00
IX balance_sheet (annual, 2024-03-31) — Gains Losses Not Affecting Retained Earnings: 357148000000.00
IX income_statement (annual, 2024-03-31) — General And Administrative Expense: 1418256000000.00
IX balance_sheet (annual, 2024-03-31) — Gross PPE: 2093054000000.00
IX balance_sheet (annual, 2024-03-31) — Held To Maturity Securities: 0.00
IX income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: 1724000000.00
IX balance_sheet (annual, 2024-03-31) — Income Tax Payable: 65534000000.00
IX income_statement (annual, 2024-03-31) — Insurance And Claims: 433863000000.00
IX income_statement (annual, 2024-03-31) — Interest Expense: 188328000000.00
IX income_statement (annual, 2024-03-31) — Interest Income: 348001000000.00
IX balance_sheet (annual, 2024-03-31) — Invested Capital: 10141937000000.00
IX cash_flow (annual, 2024-03-31) — Investing Cash Flow: -1372803000000.00
IX balance_sheet (annual, 2024-03-31) — Investments And Advances: 4576966000000.00
IX cash_flow (annual, 2024-03-31) — Issuance Of Debt: 1218867000000.00
IX balance_sheet (annual, 2024-03-31) — Long Term Debt: 5629684000000.00
IX balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 5629684000000.00
IX cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 1218867000000.00
IX cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -1177803000000.00
IX balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 1313887000000.00
IX balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 248458000000.00
IX balance_sheet (annual, 2024-03-31) — Minority Interest: 80499000000.00
IX income_statement (annual, 2024-03-31) — Minority Interests: 7545000000.00
IX cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 97039000000.00
IX cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: -50001000000.00
IX balance_sheet (annual, 2024-03-31) — Net Debt: 5167661000000.00
IX income_statement (annual, 2024-03-31) — Net Income: 346132000000.00
IX income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 346132000000.00
IX income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 338587000000.00
IX income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 346132000000.00
IX income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 346132000000.00
IX cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 338587000000.00
IX income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 338587000000.00
IX income_statement (annual, 2024-03-31) — Net Interest Income: 159673000000.00
IX cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -471085000000.00
IX cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 51815000000.00
IX cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 41064000000.00
IX cash_flow (annual, 2024-03-31) — Net Other Financing Charges: 14181000000.00
IX cash_flow (annual, 2024-03-31) — Net Other Investing Changes: 12545000000.00
IX balance_sheet (annual, 2024-03-31) — Net PPE: 2093054000000.00
IX cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -938150000000.00
IX cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 10751000000.00
IX balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 3941466000000.00
IX balance_sheet (annual, 2024-03-31) — Non Current Deferred Liabilities: 505190000000.00
IX balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 505190000000.00
IX income_statement (annual, 2024-03-31) — Normalized Income: 25769874384.81
IX cash_flow (annual, 2024-03-31) — Operating Cash Flow: 1243402000000.00
IX cash_flow (annual, 2024-03-31) — Operating Gains Losses: -166331000000.00
IX income_statement (annual, 2024-03-31) — Operating Revenue: 1796990000000.00
IX balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 1151485206.00
IX balance_sheet (annual, 2024-03-31) — Other Current Borrowings: 556938000000.00
IX balance_sheet (annual, 2024-03-31) — Other Equity Adjustments: 357148000000.00
IX income_statement (annual, 2024-03-31) — Other Gand A: 627633000000.00
IX cash_flow (annual, 2024-03-31) — Other Non Cash Items: 435497000000.00
IX income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 4671000000.00
IX balance_sheet (annual, 2024-03-31) — Other Properties: 1844596000000.00
IX balance_sheet (annual, 2024-03-31) — Other Receivables: 1868574000000.00
IX balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 2665478000000.00
IX balance_sheet (annual, 2024-03-31) — Payables: 428038000000.00
IX balance_sheet (annual, 2024-03-31) — Payables And Accrued Expenses: 428038000000.00
IX balance_sheet (annual, 2024-03-31) — Preferred Securities Outside Stock Equity: 2645000000.00
IX income_statement (annual, 2024-03-31) — Pretax Income: 469975000000.00
IX cash_flow (annual, 2024-03-31) — Purchase Of Business: -42486000000.00
IX cash_flow (annual, 2024-03-31) — Purchase Of Investment: -794700000000.00
IX cash_flow (annual, 2024-03-31) — Purchase Of PPE: -1200874000000.00
IX balance_sheet (annual, 2024-03-31) — Receivables: 2269942000000.00
IX income_statement (annual, 2024-03-31) — Reconciled Depreciation: 364242000000.00
IX income_statement (annual, 2024-03-31) — Rent And Landing Fees: 356760000000.00
IX income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 356760000000.00
IX cash_flow (annual, 2024-03-31) — Repayment Of Debt: -1177803000000.00
IX cash_flow (annual, 2024-03-31) — Repurchase Of Capital Stock: -50001000000.00
IX income_statement (annual, 2024-03-31) — Restructuring And Mergern Acquisition: 0.00
IX balance_sheet (annual, 2024-03-31) — Retained Earnings: 3259730000000.00
IX income_statement (annual, 2024-03-31) — Salaries And Wages: 352333000000.00
IX cash_flow (annual, 2024-03-31) — Sale Of Business: 139525000000.00
IX cash_flow (annual, 2024-03-31) — Sale Of Investment: 323615000000.00
IX cash_flow (annual, 2024-03-31) — Sale Of PPE: 262724000000.00
IX income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 106648000000.00
IX income_statement (annual, 2024-03-31) — Selling General And Administration: 1418256000000.00
IX balance_sheet (annual, 2024-03-31) — Share Issued: 1214961054.00
IX cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 10751000000.00
IX income_statement (annual, 2024-03-31) — Special Income Charges: 70764000000.00
IX balance_sheet (annual, 2024-03-31) — Stockholders Equity: 3941466000000.00
IX balance_sheet (annual, 2024-03-31) — Tangible Book Value: 3941466000000.00
IX income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 124315874384.81
IX income_statement (annual, 2024-03-31) — Tax Provision: 131388000000.00
IX income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.28
IX balance_sheet (annual, 2024-03-31) — Total Assets: 16322100000000.00
IX balance_sheet (annual, 2024-03-31) — Total Capitalization: 9571150000000.00
IX balance_sheet (annual, 2024-03-31) — Total Debt: 6200471000000.00
IX balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 4021965000000.00
IX balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 12300135000000.00
IX balance_sheet (annual, 2024-03-31) — Total Tax Payable: 65534000000.00
IX income_statement (annual, 2024-03-31) — Total Unusual Items: 444678000000.00
IX income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 444678000000.00
IX balance_sheet (annual, 2024-03-31) — Trading Securities: 0.00
IX balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 63475848.00
IX balance_sheet (annual, 2024-03-31) — Treasury Stock: 129980000000.00
IX balance_sheet (quarterly, 2024-09-30) — Commercial Paper: 108312000000.00
IX income_statement (quarterly, 2024-09-30) — Other Non Interest Expense: 66387000000.00
IX balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 2601080000000.00
IX balance_sheet (quarterly, 2024-09-30) — Properties: 696139000000.00
IX income_statement (quarterly, 2024-12-31) — +Total Revenue: 499010000000.00
IX balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 298393000000.00
IX balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 399146000000.00
IX balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 234054000000.00
IX balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 3357514000000.00
IX balance_sheet (quarterly, 2024-12-31) — Capital Stock: 221111000000.00
IX balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 1117631000000.00
IX balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 1250051000000.00
IX balance_sheet (quarterly, 2024-12-31) — Common Stock: 221111000000.00
IX balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 4086346000000.00
IX balance_sheet (quarterly, 2024-12-31) — Current Debt: 737905000000.00
IX balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 737905000000.00
IX income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 88831000000.00
IX income_statement (quarterly, 2024-12-31) — Gain On Sale Of Business: 12783000000.00
IX income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 6312000000.00
IX balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 418276000000.00
IX income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 391984000000.00
IX balance_sheet (quarterly, 2024-12-31) — Gross PPE: 2993682000000.00
IX income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 172000000.00
IX balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 575005000000.00
IX income_statement (quarterly, 2024-12-31) — Insurance And Claims: 135315000000.00
IX income_statement (quarterly, 2024-12-31) — Interest Expense: 40540000000.00
IX income_statement (quarterly, 2024-12-31) — Interest Income: 81139000000.00
IX balance_sheet (quarterly, 2024-12-31) — Invested Capital: 10591938000000.00
IX balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 4705490000000.00
IX balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 5767687000000.00
IX balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 5767687000000.00
IX balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 1347976000000.00
IX balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 253420000000.00
IX balance_sheet (quarterly, 2024-12-31) — Minority Interest: 84340000000.00
IX income_statement (quarterly, 2024-12-31) — Minority Interests: -739000000.00
IX balance_sheet (quarterly, 2024-12-31) — Net Debt: 5387961000000.00
IX income_statement (quarterly, 2024-12-31) — Net Income: 88831000000.00
IX income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 88831000000.00
IX income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 89570000000.00
IX income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 88831000000.00
IX income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 88831000000.00
IX income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 89570000000.00
IX income_statement (quarterly, 2024-12-31) — Net Interest Income: 40599000000.00
IX balance_sheet (quarterly, 2024-12-31) — Net PPE: 2993682000000.00
IX balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 4086346000000.00
IX income_statement (quarterly, 2024-12-31) — Normalized Income: 22298064390.04
IX income_statement (quarterly, 2024-12-31) — Operating Revenue: 499010000000.00
IX balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 1136167890.00
IX balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 737905000000.00
IX balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 418276000000.00
IX income_statement (quarterly, 2024-12-31) — Other Gand A: 155973000000.00
IX income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -7057000000.00
IX balance_sheet (quarterly, 2024-12-31) — Other Properties: 2064031000000.00
IX balance_sheet (quarterly, 2024-12-31) — Other Receivables: 1195851000000.00
IX balance_sheet (quarterly, 2024-12-31) — Payables: 873398000000.00
IX balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 873398000000.00
IX balance_sheet (quarterly, 2024-12-31) — Preferred Securities Outside Stock Equity: 2798000000.00
IX income_statement (quarterly, 2024-12-31) — Pretax Income: 126386000000.00
IX balance_sheet (quarterly, 2024-12-31) — Properties: 676231000000.00
IX balance_sheet (quarterly, 2024-12-31) — Receivables: 1594997000000.00
IX income_statement (quarterly, 2024-12-31) — Rent And Landing Fees: 100696000000.00
IX income_statement (quarterly, 2024-12-31) — Rent Expense Supplemental: 100696000000.00
IX balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 3395761000000.00
IX income_statement (quarterly, 2024-12-31) — Selling General And Administration: 391984000000.00
IX balance_sheet (quarterly, 2024-12-31) — Share Issued: 1214961054.00
IX income_statement (quarterly, 2024-12-31) — Special Income Charges: 12611000000.00
IX balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 4086346000000.00
IX balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 4086346000000.00
IX income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 27347064390.04
IX income_statement (quarterly, 2024-12-31) — Tax Provision: 36816000000.00
IX income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.29
IX balance_sheet (quarterly, 2024-12-31) — Total Assets: 16917024000000.00
IX balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 9854033000000.00
IX balance_sheet (quarterly, 2024-12-31) — Total Debt: 6505592000000.00
IX balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 4170686000000.00
IX balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 12746338000000.00
IX balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 575005000000.00
IX income_statement (quarterly, 2024-12-31) — Total Unusual Items: 93880000000.00
IX income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 93880000000.00
IX balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 78793164.00
IX balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 182856000000.00
IX income_statement (annual, 2025-03-31) — +Total Revenue: 1829238000000.00
IX income_statement (quarterly, 2025-03-31) — +Total Revenue: 440642000000.00
IX balance_sheet (annual, 2025-03-31) — Accounts Payable: 339787000000.00
IX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 339787000000.00
IX balance_sheet (annual, 2025-03-31) — Accounts Receivable: 411012000000.00
IX balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 411012000000.00
IX balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 234193000000.00
IX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 234193000000.00
IX cash_flow (annual, 2025-03-31) — Asset Impairment Charge: 25933000000.00
IX balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 626910000000.00
IX balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 626910000000.00
IX income_statement (annual, 2025-03-31) — Basic Average Shares: 1142503000.00
IX income_statement (annual, 2025-03-31) — Basic EPS: 307.74
IX cash_flow (annual, 2025-03-31) — Beginning Cash Position: 1185307000000.00
IX cash_flow (annual, 2025-03-31) — Capital Expenditure: -1357672000000.00
IX balance_sheet (annual, 2025-03-31) — Capital Stock: 221111000000.00
IX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 221111000000.00
IX balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 1206573000000.00
IX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1206573000000.00
IX balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 1321983000000.00
IX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 1321983000000.00
IX cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -135590000000.00
IX cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Financing Activities: 149322000000.00
IX cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Investing Activities: -1309695000000.00
IX cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Operating Activities: 1300193000000.00
IX cash_flow (annual, 2025-03-31) — Change In Income Tax Payable: -9232000000.00
IX cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -9839000000.00
IX cash_flow (annual, 2025-03-31) — Change In Other Working Capital: 296745000000.00
IX cash_flow (annual, 2025-03-31) — Change In Payable: -13142000000.00
IX cash_flow (annual, 2025-03-31) — Change In Payables And Accrued Expense: -13142000000.00
IX cash_flow (annual, 2025-03-31) — Change In Receivables: -2641000000.00
IX cash_flow (annual, 2025-03-31) — Change In Tax Payable: -9232000000.00
IX cash_flow (annual, 2025-03-31) — Change In Working Capital: 271123000000.00
IX cash_flow (annual, 2025-03-31) — Changes In Account Receivables: -2641000000.00
IX cash_flow (annual, 2025-03-31) — Changes In Cash: 139820000000.00
IX balance_sheet (annual, 2025-03-31) — Commercial Paper: 7588000000.00
IX balance_sheet (quarterly, 2025-03-31) — Commercial Paper: 7588000000.00
IX balance_sheet (annual, 2025-03-31) — Common Stock: 221111000000.00
IX balance_sheet (quarterly, 2025-03-31) — Common Stock: 221111000000.00
IX cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -135590000000.00
IX balance_sheet (annual, 2025-03-31) — Common Stock Equity: 4089782000000.00
IX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 4089782000000.00
IX cash_flow (annual, 2025-03-31) — Common Stock Payments: -53518000000.00
IX balance_sheet (annual, 2025-03-31) — Current Debt: 549680000000.00
IX balance_sheet (quarterly, 2025-03-31) — Current Debt: 549680000000.00
IX balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 549680000000.00
IX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 549680000000.00
IX cash_flow (annual, 2025-03-31) — Deferred Income Tax: 23346000000.00
IX cash_flow (annual, 2025-03-31) — Deferred Tax: 23346000000.00
IX cash_flow (annual, 2025-03-31) — Depreciation Amortization Depletion: 399527000000.00
IX cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 399527000000.00
IX income_statement (annual, 2025-03-31) — Diluted Average Shares: 1144778000.00
IX income_statement (annual, 2025-03-31) — Diluted EPS: 307.16
IX income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 351630000000.00
IX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 79853000000.00
IX cash_flow (annual, 2025-03-31) — Earnings Losses From Equity Investments: -57182000000.00
IX cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: -3144000000.00
IX cash_flow (annual, 2025-03-31) — End Cash Position: 1321983000000.00
IX cash_flow (annual, 2025-03-31) — Financing Cash Flow: 149322000000.00
IX cash_flow (annual, 2025-03-31) — Free Cash Flow: -57479000000.00
IX cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: 6772000000.00
IX cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of Business: -87705000000.00
IX cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -76633000000.00
IX income_statement (annual, 2025-03-31) — Gain On Sale Of Business: 87705000000.00
IX income_statement (quarterly, 2025-03-31) — Gain On Sale Of Business: 43419000000.00
IX income_statement (annual, 2025-03-31) — Gain On Sale Of Security: 11271000000.00
IX income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -1368000000.00
IX balance_sheet (annual, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 341298000000.00
IX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 341298000000.00
IX income_statement (annual, 2025-03-31) — General And Administrative Expense: 1425628000000.00
IX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 359757000000.00
IX balance_sheet (annual, 2025-03-31) — Gross PPE: 2131188000000.00
IX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 2131188000000.00
IX income_statement (annual, 2025-03-31) — Impairment Of Capital Assets: 25933000000.00
IX income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 25255000000.00
IX balance_sheet (annual, 2025-03-31) — Income Tax Payable: 53149000000.00
IX balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 53149000000.00
IX income_statement (annual, 2025-03-31) — Insurance And Claims: 384753000000.00
IX income_statement (quarterly, 2025-03-31) — Insurance And Claims: 82575000000.00
IX income_statement (annual, 2025-03-31) — Interest Expense: 169051000000.00
IX income_statement (quarterly, 2025-03-31) — Interest Expense: 44794000000.00
IX income_statement (annual, 2025-03-31) — Interest Income: 328356000000.00
IX income_statement (quarterly, 2025-03-31) — Interest Income: 82483000000.00
IX balance_sheet (annual, 2025-03-31) — Invested Capital: 10372580000000.00
IX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 10372580000000.00
IX cash_flow (annual, 2025-03-31) — Investing Cash Flow: -1309695000000.00
IX balance_sheet (annual, 2025-03-31) — Investments And Advances: 4554562000000.00
IX balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 4554562000000.00
IX cash_flow (annual, 2025-03-31) — Issuance Of Debt: 1549750000000.00
IX balance_sheet (annual, 2025-03-31) — Long Term Debt: 5733118000000.00
IX balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 5733118000000.00
IX balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 5733118000000.00
IX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 5733118000000.00
IX cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 1549750000000.00
IX cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -1368479000000.00
IX balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 1320015000000.00
IX balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 1320015000000.00
IX balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 315049000000.00
IX balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 315049000000.00
IX balance_sheet (annual, 2025-03-31) — Minority Interest: 82001000000.00
IX balance_sheet (quarterly, 2025-03-31) — Minority Interest: 82001000000.00
IX income_statement (annual, 2025-03-31) — Minority Interests: -5000000.00
IX income_statement (quarterly, 2025-03-31) — Minority Interests: -83000000.00
IX cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 21172000000.00
IX cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: -53518000000.00
IX balance_sheet (annual, 2025-03-31) — Net Debt: 5076225000000.00
IX balance_sheet (quarterly, 2025-03-31) — Net Debt: 5076225000000.00
IX income_statement (annual, 2025-03-31) — Net Income: 351630000000.00
IX income_statement (quarterly, 2025-03-31) — Net Income: 79853000000.00
IX income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 351630000000.00
IX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 79853000000.00
IX income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 351635000000.00
IX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 79936000000.00
IX income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 351630000000.00
IX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 79853000000.00
IX income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 351630000000.00
IX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 79853000000.00
IX cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 351635000000.00
IX income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 351635000000.00
IX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 79936000000.00
IX income_statement (annual, 2025-03-31) — Net Interest Income: 159305000000.00
IX income_statement (quarterly, 2025-03-31) — Net Interest Income: 37689000000.00
IX cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -168264000000.00
IX cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 132650000000.00
IX cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 181271000000.00
IX cash_flow (annual, 2025-03-31) — Net Other Financing Charges: 1746000000.00
IX cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 24969000000.00
IX balance_sheet (annual, 2025-03-31) — Net PPE: 2131188000000.00
IX balance_sheet (quarterly, 2025-03-31) — Net PPE: 2131188000000.00
IX cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -983868000000.00
IX cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -48621000000.00
IX balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 4089782000000.00
IX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 4089782000000.00
IX balance_sheet (annual, 2025-03-31) — Non Current Deferred Liabilities: 525632000000.00
IX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 525632000000.00
IX balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 525632000000.00
IX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 525632000000.00
IX income_statement (annual, 2025-03-31) — Normalized Income: 30576793207.80
IX income_statement (quarterly, 2025-03-31) — Normalized Income: -21358428383.08
IX cash_flow (annual, 2025-03-31) — Operating Cash Flow: 1300193000000.00
IX cash_flow (annual, 2025-03-31) — Operating Gains Losses: -214194000000.00
IX income_statement (annual, 2025-03-31) — Operating Revenue: 1829238000000.00
IX income_statement (quarterly, 2025-03-31) — Operating Revenue: 440642000000.00
IX balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 1136289549.00
IX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 1136289549.00
IX balance_sheet (annual, 2025-03-31) — Other Current Borrowings: 542092000000.00
IX balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 542092000000.00
IX balance_sheet (annual, 2025-03-31) — Other Equity Adjustments: 341298000000.00
IX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 341298000000.00
IX income_statement (annual, 2025-03-31) — Other Gand A: 646054000000.00
IX income_statement (quarterly, 2025-03-31) — Other Gand A: 175856000000.00
IX cash_flow (annual, 2025-03-31) — Other Non Cash Items: 424100000000.00
IX income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: -27128000000.00
IX income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -9169000000.00
IX balance_sheet (annual, 2025-03-31) — Other Properties: 1816139000000.00
IX balance_sheet (quarterly, 2025-03-31) — Other Properties: 1816139000000.00
IX balance_sheet (annual, 2025-03-31) — Other Receivables: 1967178000000.00
IX balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1967178000000.00
IX balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 2607637000000.00